Anthony Blaszczyk

Anthony Blaszczyk is a seasoned scientist with extensive experience in analytical development and biochemistry. Currently serving as a Senior Scientist at US Pharmacopeia since January 2023, Anthony previously managed the Analytical Development Department at Catalent Pharma Solutions, overseeing four specialized teams and a total of 14 scientists. Earlier roles include contributions to vaccine and AAV drug product characterization at Catalent and work in the Separations/Chromatography group at NOVAVAX INC, focusing on protein drug product characterization. Anthony's academic background includes a PhD in Biochemistry and Molecular Biology from Penn State University and a BS in Biochemistry from Allegheny College.